Healthcare -
Biotechnology - NASDAQ - US
$ 8.02
-0.125 %
$ 178 M
Market Cap
-3.68
P/E
INMB - CASH & EQUIVALENTS
Cash & Equivalents INMB - INmune Bio, Inc.
35.8 M
LAST VALUE
-30.78%
2 YEAR CAGR
186.35%
5 YEAR CAGR
0.00%
10 YEAR CAGR